Dendreon Corporation

SEATTLE and MILAN, October 9, 2010 - Dendreon Corporation (Nasdaq: DNDN) today announced the following data presentations taking place at the 35th European Society for Medical Oncology (ESMO) congress in Milan, Italy: - Saturday, October 9, 2010, 13:00 - 14:00 CEST - "Integrated Safety Results from 4 Randomized, Double-blind, Placebo-controlled Studies of Sipuleucel-T." Poster presentation.